Article Text

PDF

PS-202 Influence Of Moderate Permissive Hypercapnia On Pulmonal Inflammation In Extremely Low Birthweight Infants (elbwi)
  1. S Gentner1,
  2. U Uhlig2,
  3. HD Hummler3,
  4. UH Thome4
  1. 1Department of Cardiac Thoracic and Vascular Surgery, University Hospital Ulm, Ulm, Germany
  2. 2Department of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany
  3. 3Department of Pediatrics, Children’s Hospital University of Ulm, Ulm, Germany
  4. 4Department of Neonatology, University of Leipzig, Leipzig, Germany

Abstract

Background and aims We tested the hypothesis that moderate permissive hypercapnia (PHC) results in less lung injury than mild hypercapnia (MHC) and therefore may reduce the concentration of proinflammatory cytokines and acid sphingomyelinase (ASMase) in tracheal aspirates.

Methods Preterm infants (birthweight 400–1000 g, gestational age 23 0/7–28 6/7 weeks) requiring mechanical ventilation within the first 24 h after birth, were randomised to receive either PHC (PaCO2 target area starting with 55–65 mm Hg at day 1 to 65–75 mm Hg at day 7) or MHC (PaCO2 target area starting with 40–50 mm Hg at day 1 to 50–60 mm Hg at day 7). Tracheal aspirates were collected and analysed for IL-1β, IL-6, IL-8, IL-10, MIP-1α, LTB4, TGF-β1, NPY, albumin, nitrate, ASMase and the secretory component for IgA. The primary endpoint BPD or death was determined at a postmenstrual age of 36 weeks ± 1 day.

Results 71 infants were enrolled, 35 received PHC and 36 MHC. Analyses of variance for the main effect of the PaCO2 targets did not detect significant differences: IL-1β (p = 0,42), IL-6 (p = 0,44), IL-8 (p = 0,91), IL-10 (p = 0,87), MIP-1α (p = 0,34), LTB4 (p = 0,87), TGF-β1 (p = 0,26), NPY (p = 0,47), albumin (p = 0,63), nitrate (p = 0,73), ASMase (p = 0,25). BPD or death occured in 9 (26%) and in 10 (28%) of infants receiving PHC or MHC.

Conclusion PHC did not result in lower inflammatory activity than MHC in ventilated ELBWI.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.